Drugs Controller General Of India (DCGI)

Thursday, Apr 18, 2024 | Last Update : 06:57 PM IST

Drugs Controller General of India (DCGI)

EUA to Biological E's COVID-19 vaccine Corbevax for the 12 to 18 years age group, subject to certain conditions. (Representational Photo: PTI))

DCGI grants restricted EUA to Covid jab Corbevax for 12-18 age group

the government has not taken a decision yet on vaccinating those aged below 15 years

22 Feb 2022 12:18 AM

A municipal corporation worker shows vials of COVID-19 vaccine before administering to beneficiaries, at a KMC health centre in Kolkata. (Photo:PTI)

Two COVID vaccines may cost Rs. 275 after market nod

The National Pharmaceutical Pricing Authority (NPPA) has already been directed to start working towards capping the price

27 Jan 2022 6:59 AM

The government has also decided to provide precaution doses to all personnel deployed on election duty in the poll-bound states. (AP file image)

As COVID cases rise, govt gives nod to two more vaccines, anti-viral pill

With this approval, the number of Covid-19 vaccines which have received emergency use authorisation in the country has risen to eight

28 Dec 2021 11:41 AM

In August 2020, US-based vaccine maker Novavax, Inc had announced a licence agreement with SII for the development and commercialisation of NVX-CoV2373, its COVID-19 vaccine candidate, in low and middle-income countries and India. (Reuters Photo)

CDSCO seeks more data from SII, says Covovax not yet approved in country of origin

The DCGI office had granted SII permission to manufacture and stock Covovax on May 17

28 Nov 2021 12:47 PM

A health worker carries vials of the Covaxin vaccine against the Covid-19 coronavirus at a health centre in New Dehi. (Photo: AFP/File)

AA Edit | Validation glimmer for Covaxin, hope for parents

The two-dose vaccine will be administered with a gap of 28 days

14 Oct 2021 7:26 AM

he Covishield, Covaxin and Sputnik V vaccines are being given to only those above 18 years of age and unlike ZyCoV-D, which is a three-dose vaccine, these are administered in two doses. (Photo:Zyduscadila)

ZyCoV-D to be introduced in Covid vaccination drive shortly: Govt

ZyCoV-D has received the Emergency Use Authorisation from the Drugs Controller General of India (DCGI)

30 Sep 2021 7:34 PM

Zydus Cadila's COVID-19 vaccine ZyCoV-D. (Photo:Zyduscadila)

Zydus Cadila's Covid vaccine ZyCoV-D gets approval for Emergency Use Authorisation

ZyCoV-D has become the first vaccine to be administered to those in the age group of 12-18 years in the country

20 Aug 2021 10:54 PM

A health worker holds one vial of Zydus Cadila's ZyCoV-D vaccine. (Photo: AP)

Emergency approval for Zydus Cadila to take few more days, say sources

ZyCoV-D is a DNA Covid vaccine, which carries the genetic code for that part of a virus that triggers the immune system of the body

12 Jul 2021 1:01 PM

Earlier in June, Moderna started the process to win full US regulatory approval. (Photo: AP)

DGCI likely to approve Moderna's Covid vaccine in India for emergency use

Moderna's vaccine already has been cleared for emergency use by the FDA and regulators in numerous other countries

29 Jun 2021 1:03 PM

"We hope to be able to quickly make it available through this approval," said Biophore CEO Jagadeesh Babu Rangisetty. (File image: Youtube)

Biophore applies to DCGI for emergency-use approval for COVID treatment drug

The company plans to commence commercial production of the product immediately after the approval is received

11 Jun 2021 11:29 AM

DCGI Chief VG Somani letter said that this will be applicable for vaccines that have already been approved for restricted use by the US FDA, EMA, UK MHRA, PMDA Japan or listed for Emergency Use by the World Health Organisation. (AFP)

DCGI waiver likely to bring foreign vaccines like Pfizer, Moderna a step closer

Earlier, vaccines that had completed clinical studies outside the country were required to carry out 'bridging trials' on Indian people

02 Jun 2021 1:00 PM

Zydus Cadila's potential covid drug may begin human clinical trials

India’s 'first' indigenous COVID-19 vaccine candidate Covaxin had also got the nod for human clinical trials recently

03 Jul 2020 11:01 AM

1 of 1

Columns

Syed Ata Hasnain